Abstract
Lung cancer is one of the deadliest forms of cancer affecting society today. Non-coding RNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), through the transcriptional, post-transcriptional, and epigenetic changes they impose, have been found to be dysregulated to affect lung cancer tumorigenesis and metastasis. This review will briefly summarize hallmarks involved in lung cancer initiation and progression. For initiation, these hallmarks include tumor initiating cells, immortalization, activation of oncogenes and inactivation of tumor suppressors. Hallmarks involved in lung cancer progression include metastasis and drug tolerance and resistance. The targeting of these hallmarks with non-coding RNAs can affect vital metabolic and cell signaling pathways, which as a result can potentially have a role in cancerous and pathological processes. By further understanding non-coding RNAs, researchers can work towards diagnoses and treatments to improve early detection and clinical response.
Author supplied keywords
- (ACLY)
- (AKT)
- (CCNE1)
- (CDH1)
- ATPlyaseaconitasecitrateE-cadherin(ACLY)
- Aconitaseα-Ketoglutaratecyclinaconitase(ACO)
- Bromodomain-containingserine/threoninekinaseserine/threonineprotein(AKT)
- Cancer metabolism
- CitratekinasecyclinATPlyase(AKT)
- Dehydrogenase⍺-Ketoglutarate ⍺Ketoglutarate(α-KGDH)
- Dependent(ACO)
- E1citrate(ACLY)
- Immortalization
- Kinase4ATP(BRD4)
- Long non-coding RNA
- Lung cancer
- Lyase(ACO)
- MicroRNA
- Oncogene
- RNA editing
- RNA modifications
- Tumor initiation
- Tumor progression
Cite
CITATION STYLE
Santos, R. M., Moreno, C., & Zhang, W. C. (2020). Non-coding rnas in lung tumor initiation and progression. International Journal of Molecular Sciences, 21(8). https://doi.org/10.3390/ijms21082774
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.